Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 13 results found. Search for [ Rajeev Nannapaneni ]

Results 1 to 13 of 13
February 25, 2019
Sujeet Kumar, Co-founder, Udaan; Rajeev Nannapaneni, CEO, Natco Pharma Ltd; Dr Rajeev Shorey, Principal Scientist, TCS Innovation Labs and Adjunct Faculty, IIT Delhi; and Lula Mohanty, General Manager, Global Business Services, IBM India/ South Asia talk about reinventing themselves.

February 14, 2019
Congratulating the czars of the corporate world, Union Minister Nitin Gadkari, said, \"Team is more important than technology and resources; a competent CEO will face problems if he doesn't have a good team.\"

E Kumar Sharma
New Delhi, February 14, 2019
Despite no big product launches in the US last year, Natco Pharma gained from its strategy of focussing on a few big products. It now hopes to build on this.

February 13, 2019
Union Minister Nitin Gadkari honours the successful CEOs from various sectors during the BT Mindrush 2019.
January 13, 2018
Business Today will host the fifth edition of MindRush - India Today Group's annual flagship business event. The one-day conference will take place on January 13 at St Regis, Mumbai. Here are the highlights.

E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.

E. Kumar Sharma
Delhi, April 1, 2017
Leading Indian pharmaceutical companies are facing competition in the US from relatively smaller firms back home.

E Kumar Sharma
September 24, 2014
\"This is for the first time, I think, that a pharma policy has been rolled back... It is a very positive move,\" Biocon Chairperson and MD Kiran Mazumdar-Shaw said.

Rajeev Nannapaneni
May 26, 2014
Rajeev Nannapaneni, vice-chairman and CEO, Natco Pharma, on three issues in the pharmaceutical sector that need to be addressed and the possible solutions.

E. Kumar Sharma
July 27, 2013
At the second Business Today breakfast meet, held in Hyderabad, CEOs brainstormed on ways to spur innovation, particularly in a downturn.

E Kumar Sharma
April 1, 2013
The Supeme Court has refused protection for Novartis' blood cancer drug Glivec on the grounds that it is not a new medicine but only an amended version of a known compound.

Rachna M. Koppikar & Rahul Sachit Anand
October 23, 2009
The first and worst hit by the downturn, the financial services sector has started to grow and hire. Healthcare, IT and ITES also get into the hiring mode.

E. Kumar Sharma
August 19, 2009
By refocussing its strategies, Natco Pharma has pulled back from the brink of bankruptcy to power ahead in cancer drugs. Now it is looking for niche areas globally. Can it scale up and take on global competition?